ARCHIVES

Rosenberg’s Latest Results: 22% Response Seen With LAK/IL-2, 13% With High Dose IL-2 Alone

This article is from The Cancer Letter archive.

Vol. 13 No. 15 | April 10, 1987

Download PDF Visit The Full Archive

Related Articles

DCT Survey Shatters Myth That Young Investigator Have Difficulty Getting Grants – They’re Doing Better Than Those Over Age 40

August 3, 1984

DCT Advisors Okay Two New RFA Concepts In Clinical Research, Biodiversity Groups

November 8, 1991

ASCO Backs Sentinel Node Biopsy In Some Early Stage Breast Cancer

September 30, 2005

NCCAM Trial Tests Electroacupuncture for Delayed Nausea.

June 14, 2002

Chabner Calls For Audit Of I-ELCAP Data, Full Financial Disclosure.

May 2, 2008

In Brief: Radiologists Elect Officers, Award Medals; FDA Advisors Okay Test For Breast Cancer

September 29, 1995